Home / Health / Meningitis B Vaccine Shortage Sparks Pharmacy Rush
Meningitis B Vaccine Shortage Sparks Pharmacy Rush
20 Mar
Summary
- Two deaths from meningitis B outbreak fueled vaccine demand.
- Pharmacies report being inundated with requests for the vaccine.
- Government released 20,000 doses to ease private market shortages.
Following two fatalities from a meningitis B outbreak in Kent, there has been a significant increase in demand for the vaccine. Young people and concerned individuals are seeking protection, leading to warnings of shortages from pharmacies nationwide. Private demand has surged, with major pharmacy chains implementing waiting lists.
The UK Health Security Agency is providing the vaccine and antibiotics to those potentially exposed. To address shortages, the government released 20,000 doses of the meningitis B vaccine from the NHS supply for the private market. However, this quantity is anticipated to be insufficient to meet the high demand.
The outbreak has also reignited discussions about expanding access to the meningitis B vaccine for teenagers, who are considered a high-risk group. Health officials are re-examining eligibility criteria for the vaccine on the NHS, considering cost-benefit analyses for public health interventions.
While antibiotics offer immediate protection for those exposed, the meningitis B vaccine requires a two-dose course to build immunity. The decision to expand NHS vaccination programs will depend on further evidence and cost-effectiveness assessments by advisory bodies.
